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Abstract 
The attachment of mouse immunoglobulin G (IgG) and anti-mouse IgG antibodies onto 
carbon nanotubes (CNTs), using either non-covalent or covalent means was investigated.  
The resultant CNTs were characterised using a variety of techniques including enzyme-
linked and fluorescence-linked immunoassays, UV-visible-NIR and Raman spectroscopy, 
transmission electron microscopy and cyclic voltammetry.  TEM images of the adsorbed 
antibody on the CNTs show that the covalent modification approach was successful, 
whereas the non-covalent approach resulted in no electrochemically detectable labelled 
antibody.  Direct electrical communication between CNTs covalently linked to 
peroxidase-labelled antibodies was observed during cyclic voltammetry, which indicates 
applications in developing carbon-nanotube-based immunosensors. 
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1. Introduction 
Many new biomarkers associated with different stages of disease have been elucidated by 
genomics and proteomics research and their efficient detection may lead to early 
diagnosis. Extensive use of these disease markers in healthcare depends on developing 
techniques that allow the rapid detection of these markers with high selectivity and 
sensitivity. Advances in molecular detection currently focus on several areas including 
developing new methods for quantitation of a specific binding event through 
electrochemical or electronic measurements. Nanomaterials such as quantum dots, 
nanoparticles, nanotubes, and nanowires may have potential for developing assays with 
improved sensitivity in recognising a specific binding event. This may involve the use of 
nano-sized electrodes based on carbon nanotubes (CNTs). 
 
The development of miniaturised transducers capable of selectively determining the 
presence and/or concentration of analytes is greatly facilitated by immobilisation of 
enzymes and antibodies onto CNTs. Due to their unique mechanical and electrical 
properties CNTs are one of the most widely studied nanomaterials [1]. Compared to 
other carbon electrodes, CNT-modified electrodes have shown superior performances in 
electrochemical studies of biologically relevant molecules such as hydrogen peroxide [2], 
reduced nicotinamide adenine dinucleotide (NADH) [3] and dopamine [4]. CNTs are an 
attractive material in bio-electrochemistry with the dual benefits of their electrical 
conductivity and the nanotopography they provide in electrode structures. The latter 
property maximises the possibility of bringing CNTs into close proximity with proteins 
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and enables CNTs to act as one dimensional nanochannels for the electron transfer in 
proteins [5, 7, 8].  
 
Molecules with specific recognition sites must be tethered onto the nanotube surface to 
facilitate a predictable alteration in nanotube electronics, triggered by the binding of 
target analyte molecules. CNTs are receptive to functionalisation either by oxidative 
processes that form reactive groups, or through direct covalent or non-covalent 
modification of the sidewalls. Covalent attachment involves direct attachment of the 
functionality to the CNTs via the formation of chemical bonds, altering carbon-carbon 
bonds from sp2 to sp3 structure leading to a loss of conjugation and a subsequent change 
in electronic properties. Non-covalent attachment involves CNT-molecule interactions 
involving electrostatic, van der Waals and/or hydrophobic interactions and preserves the 
sp2 structures and therefore, electronic properties. However, the non-covalent molecular 
linkage is less robust than covalent linkages. Furthermore, the nature of non-covalent 
attachment may result in denaturation of the protein.  
 
The natural affinity of protein hydrophobic domains toward carbon nanotubes allows for 
non-covalent functionalisation of such biomolecules. Good electrochemical 
communication between multi-walled carbon nanotubes (MWNTs) and redox proteins 
have been observed both at the protein surface in the case of horse radish peroxidase 
(HRP) [5, 6], cytochrome C [7] and azurin [8], and deep within the protein 
macrostructure e.g. glucose oxidase [9]. Azamian et al. [10] observed adsorption of 
ferritin protein onto SWNTs which resulted in the solubilisation of SWNTs in water. In 
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contrast, Dai and co-workers reported that incubating SWNTs grown on a TEM grid in 
aqueous ferritin solution resulted in no observable adsorption [11]. More recently we 
reported how ferritin protein was non-covalently immobilised onto SWNTs bundles [12]. 
Individual SWNTs did not appear to support the ferritin molecules, which is not 
surprising given the size of the ferritin molecules (diameter ~13 nm) compared to the 
SWNTs (diameter ~1 nm). Ferritin dispersed the SWNTs well in solution, resulting in a 
smaller SWNT bundle size, but the protein must be in large excess to achieve this. Such 
adsorption/immobilisation of proteins may result in deformation of the protein tertiary 
structure to achieve pi-stacking along the nanotube walls. In contrast, use of the 
bifunctional linker, pyrenebutanoic acid succinimide ester, was reported by Dai and co-
workers to immobilise proteins on SWNT surfaces [11]. The pyrene moiety is reported to 
π-π stack with the CNT sidewall allowing the succinimidyl ester group to react with 
amines in the proteins, allowing the non-covalent immobilisation of proteins with 
retained biological activity and functionality. 
 
In addition to enzymes, biomolecules such as biotin, streptavidin [13] and antibodies 
have been used to functionalise CNTs. Wohlstadter et al. [14] used strong acid to etch a 
densely packed nanotube sheet resulting in the availability of surface carboxylic acid 
groups. Streptavidin was immobilised on the nanotube sheet by carbodiimide-activated 
coupling. The specific biotin–streptavidin interaction enabled the attachment of a 
biotinylated mAb for -fetoprotein (AFP). Prato and co-workers prepared amino acid- 
[15] and peptide-functionalised SWNTs [16]. Their two-step procedure consisted 
initially of functionalising CNTs with aminoethylene glycol. In the second step, protected 
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amino acids reacted directly with the amino groups on the CNTs [15]. Oligo- and 
polypeptides were covalently linked to these amino-CNTs via amidation with fully 
protected peptides or a succinimide–maleimido bridge [16]. In vitro immunological 
studies showed that an antigenic epitope from the foot-and-mouth disease virus retained 
the necessary active structure for interaction with specific antibodies upon attachment to 
SWNTs [16]. In the course of this work we have attached antibodies to CNTs using a 
covalent and non-covalent approach and evaluated the performance of each material as an 
electrochemical transducer. 
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2. Experimental 
SWNTs (purified, Carbon Nanotechnologies, Inc, Houston), COOH functionalised 
MWNT (MWNT-COOH, Nanocyl, Belgium), hyaluronic acid (HA, Sigma), sodium 
dodecyl sulfate (SDS, Sigma), phosphate buffered saline (PBS, Oxoid, Hampshire, 
England), mouse immunoglobulin G (IgG) (Sigma), bovine serum albumin (BSA, 
Sigma), anti-mouse IgG labelled with horse radish peroxidase (derived from goat, 
Sigma), anti-mouse IgG labelled with biotin (derived from goat, Sigma), QDOTTM605 
streptavidin conjugate (Quantum Dot Corp, California), 3,3’,5,5’-tetramethylbenzidine 
dihydrochloride (TMB, Sigma) were used as received. 
Characterisation of the samples by enzyme assay was obtained using a Tecan 
Safire2 microplate reader. Absorbance readings were taken at a wavelength of 450 nm. 
Fluorescence analysis of the samples was obtained using an excitation wavelength of 450 
nm and an emission wavelength of 605 nm. UV-visible-NIR spectra of the samples were 
examined over the range of 300-1400 nm (Varian Cary 500 Scan UV-visible-NIR 
spectrophotometer). Raman spectroscopy measurements were performed using a Jobin 
Yvon Horiba HR800 Spectrometer equipped with a He:Ne laser (λ = 632.8 nm) utilising 
a 950-line grating. Transmission electron microscopy (TEM) analysis was performed 
using a Jeol 1400 microscope (100 kV). Cyclic voltammetry was performed using an 
eDAQ e-corder (401) and potentiostat/galvanostat (EA 160) with Chart v5.1.2/EChem v 
2.0.2 software (ADInstruments), and a PC computer in phosphate buffered saline solution 
(PBS - 0.2 M, pH=7.4) with Ag/AgCl reference electrode and platinum mesh counter 
electrode. 
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2.1 CNT preparation 
CNT dispersions were prepared in the following manner: HA-SWNT dispersions were 
prepared from an aqueous solution of HA (0.4 wt %) containing SWNT in a ratio of 3:2, 
which was ultra-sonicated using pulse (2s on, 1s off) for 30 minutes using a high power 
sonic tip (500 W, 30% amplitude). This dispersion (300 l) was dispersed in 9.66 ml 
water resulting in a final concentration of 180 mg l-1 of CNTs. 
Two milligrammes of MWNT-COOH were prepared in 10ml of distilled water 
containing 1% (v/v) SDS to aid dispersion. These tubes were sonicated at 60 W for 3 min 
without pulse using a sonic tip and then sonicated for 1 hour (in a sonic bath). The 
nanotubes were in solution and were used without further alteration. 
 
2.2 Antibody Immobilisation onto CNTs 
2.2.1 Non-Covalent Immobilisation 
Briefly, 100μl of mouse IgG, at a concentration of 0.1 mg ml-1 was added to the CNT 
dispersions overnight with stirring at 4°C. The CNTs-IgG mixture was centrifuged and 
washed with distilled water 3 times. Any remaining unreacted sites on the CNTs were 
blocked with 5 mg ml-1 BSA and reacted for a further 3 hours at 4°C. The CNTs were 
then centrifuged (5 min at 4000 rpm) and washed 3 times with distilled water. Anti-
mouse IgG labelled with HRP was diluted 1 in 1000 in 1% (w/v) BSA/PBS and 5 mls of 
this solution was added to the CNT pellet, re-dispersed and incubated at 37°C for one 
hour. The CNTs were then centrifuged (5 min at 4000 rpm) and washed a further 3 times 
with PBS. This procedure was repeated as above using anti-mouse IgG labelled with 
biotin and streptavidin-labelled quantum dots (QDOTTM605) in place of HRP. 
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 2.2.1 Covalent Immobilisation 
Antibodies were covalently immobilised in a similar manner to the procedure described 
for non-covalent immobilisation except for the addition of 4 mg ethyl 
diaminocarbodiimide (EDC), the zero length crosslinker, to the dispersion. 
 
2.3 Antibody Detection 
HRP-labelled antibodies were detected using the 3,3,5,5-tetramethylbenzidine 
dihydrochloride (TMB) assay prepared as per the manufacturer’s instructions. 10 µl of 
the antibody-labelled CNT solution was added to a 90 µl of PBS in a microtitre well. The 
TMB solution (100 µl) was then added to the well and incubated in the dark at room 
temperature for 20 min.  The reaction was stopped by the addition of 50 µl of 10% (v/v) 
HCl and the absorbance was read at 450 nm in a Tecan Safire2 microplate reader.   
Antibodies labelled with biotin were detected using streptavidin-labelled quantum dots. 
Antibody-labelled CNT solutions (10 µl) were added to PBS in a microtitre well (90 µl). 
The QDOTTM 605 streptavidin conjugate (100 µl of a 20 nM solution) was added to the 
well and incubated at room temperature for 30 mins.  The fluorescence was determined 
using excitation at 450 nm and emission at 605 nm in the microplate reader. 
25 l of each CNT/Ab-HRP suspension was cast as a film onto clean glassy carbon 
electrodes and used as the working electrode in cyclic voltammetry. As a control, 10 mg 
MWNTs was dispersed in 10 ml water and 25 l of this suspension was cast as a film 
onto two clean glassy carbon electrodes. A further control was prepared by adding 25 l 
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of a 1 mg ml-1 HRP in PBS (0.2 M, pH=7.4) onto one of the aforementioned control 
MWNT electrodes. 
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3. Results and Discussion 
The immobilisation of antibodies onto CNTs using non-covalent or covalent attachment 
was investigated and the performance of each material as an electrochemical transducer 
was evaluated. Covalent immobilisation involved a very simple procedure of attachment 
to polysaccharides non-covalently adsorbed onto CNTs and, in a separate experiment, to 
carboxyl functionalised CNTs. Of particular interest were comparative electrochemical 
transduction capabilities between covalently and non-covalently modified CNTs. 
 
The use of either MWNTs or SWNTs was investigated in these studies. MWNT-COOH 
were dispersed with the aid of surfactant (SDS) and SWNTs were dispersed using a 
glycosaminoglycan (hyaluronic acid, HA), which was recently found to be an excellent 
dispersant for SWNTs [17]. For the non-covalent immobilisation approach, these 
dispersions were mixed with the primary antibody, mouse IgG, and named MWNT NC 
and SWNT NC. For the covalent immobilisation approach, the dispersions were mixed 
with mouse IgG and the cross linker EDC and named MWNT Cov and SWNT Cov. Non-
specific binding for both functionalisation approaches was eliminated by adsorbing BSA. 
An unlabelled antibody was immobilised onto the CNTs as future work will involve 
adaptation of this method for a sandwich immunoassay. 
 
In order to detect the presence of the immobilised antibody, a secondary antibody, anti-
mouse IgG labelled with HRP, was used. The secondary antibody was incubated with the 
primary antibody-modified CNTs (as illustrated in Figure 1). The CNT products (MWNT 
Cov-HRP, SWNT Cov-HRP, MWNT NC-HRP, SWNT NC-HRP, where Cov and NC 
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indicate covalent and non-covalent coupling strategies, respectively) were assayed using 
the colorimetric tetramethylbenzidine (TMB) enzyme assay. The TMB assay results 
(Figure 2) indicate that the presence of antibody on the covalently modified CNTs is 
considerably higher than on the non-covalently modified samples (nearly three times 
higher for SWNTs and twice as high for MWNTs). This was found to be true in the case 
of both single and multi-walled CNTs. This result suggests that the covalent 
immobilisation of antibodies on CNTs is more successful than simple adsorption in the 
case of non-covalent modification of CNTs. 
 
In an alternative coupling experiment, the secondary antibody, anti-mouse IgG labelled 
with biotin, was incubated with the primary antibody modified CNTs, followed by 
incubation with streptavidin-labelled quantum dots (QDOTs) (MWNT Cov-QDOT, 
SWNT Cov-QDOT, MWNT NC-QDOT, SWNT NC-QDOT). These CNT samples were 
analysed by fluorescence spectroscopy and Figure 3 illustrates that the covalently 
modified samples exhibited greater fluorescence than the non-covalently modified 
samples. These results again suggest that a higher concentration of antibodies are 
immobilised on CNTs using a covalent modification approach. Quantum dots have 
previously been used as fluorescence labels for biomolecules [18]. This approach should 
be widely applicable to biomolecules immobilised on CNTs since it was determined that 
there was no interference in the fluorescence emissions (Figure 3).   
 
It has been shown that the UV-visible and near infra-red spectroscopic properties of 
SWNT dispersions vary greatly with their environment due to selective interaction of 
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molecules with CNTs of different diameter and band gap [19]. The well known 
absorption peaks of the SWNTs van Hove singularities occurring between 500-1000 nm 
were observed (Figure 4). Clear differences are observed between the spectra of SWNTs 
with antibodies covalently immobilised compared with the equivalent non-covalent 
dispersions. The shift in the absorption peaks of the SWNTs in the covalently 
functionalised samples may be due to selective interaction of the SWNTs with the 
antibodies, as was previously observed with biomolecules and SWNTs [19]. This trend in 
similarities between UV-visible-NIR spectra is not seen for covalently functionalised 
MWNT samples compared with non-covalent MWNT dispersions (results not shown).  
 
Raman spectroscopy is a powerful technique for the characterisation of CNTs [20] and 
was used to determine if a difference existed in CNTs obtained using the different 
approaches to functionalisation. The D and G lines of both forms of CNT and the radial 
breathing mode (RBM) peaks of the SWNTs were examined (results not shown). No 
significant changes were observed between covalently and non-covalently functionalised 
CNTs. In the case of the covalently functionalised samples this is expected since no new 
functional groups on the CNT sidewalls were created. Existing functional groups were 
modified on the dispersant in the case of SWNTs and existing carboxyl groups on the 
MWNTs were functionalised. 
 
The RBM peaks, which are often observed between 100 and 250 cm-1, are directly linked 
to the reciprocal of the nanotube diameter. Bundled SWNTs are subject to inter-tube 
interactions which increase the frequency of the radial breathing modes. RBM peak shifts 
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are also observed when molecules interact with CNT sidewalls e.g. upon wrapping of 
CNTs with polymers/surfactants. Comparison of the Raman spectra of SWNT samples 
shows few differences and RBM shifts are not significant. In the case of covalently 
functionalised SWNT samples this is predicted, since we are modifying functional groups 
on the dispersant and not creating new ones on the CNT sidewalls. Again no significant 
RBM mode changes are observed for the non-covalently functionalised SWNTs, 
suggesting that there is little interaction between the antibody and the nanotube, and 
therefore that non-covalent functionalisation was not successful. 
 
TEM imaging of the MWNT samples provided clear evidence of whether or not proteins 
were adsorbed or functionalised on the CNT surface. Imaging of the HRP enzyme 
attached to the anti-mouse antibody is straightforward due to the metal centre of the 
peroxidase, as is TEM imaging of the metal semiconductor QDOT nanoparticles. Figure 
5 shows TEM images of MWNT samples from functionalisation strategies using both the 
HRP and QDOT labels. The size of HRP protein is ~ 5 nm in diameter [21], which was 
confirmed by dynamic light scattering experiments (4.6 nm mean size). TEM images of 
MWNT samples (Figure 5) with antibodies covalently attached clearly show the walls of 
the CNTs. It is apparent that they are covered with both conjugated antibodies and 
adsorbed polymer which may be the oligosaccharide used to disperse the CNTs and 
anchor the antibodies. In stark contrast, the MWNT samples which underwent non-
covalent immobilisation show no features which could be ascribed to either the antibody, 
BSA blocking protein, oligosaccharide dispersant or the HRP label. This may be due to 
the vigorous washing steps involved in the immobilisation protocol. 
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 The QDOT label is a nanometre-scale crystal of CdSe coated ZnS, which is further 
coated with a polymer shell that was coupled to streptavidin. This gives the QDOT label 
a size similar to that of a large macromolecule or protein (~15–20 nm). These are clearly 
evident from the TEM images in Figure 5b from the MWNT samples which were 
submitted to the covalent functionalisation procedure. On the contrary, the non-
covalently modified samples show no features of the size of the QDOT label (~15–20 
nm); indicating in both instances that the covalent approach was more successful.  
 
Electrochemical characterisation of the CNTs functionalised with anti-mouse IgG 
labelled with HRP was carried out in phosphate buffered saline as electrolyte (pH=7.4). 
Figure 6 shows the cyclic voltammograms obtained from MWNT samples drop cast as 
films on glassy carbon electrodes. No clear redox responses were observed from HRP at 
the MWNT NC-HRP sample. A pair of broad reduction/reoxidation responses was 
observed at ~ -0.33 V and -0.70 V vs. Ag/AgCl, respectively, which have previously 
been observed at oxidised MWNTs and attributed to reduction of the carboxylic acid 
groups and their subsequent reoxidation [22]. An electrode was constructed using 25 l 
of MWNTs sonicated in water and drop cast on a glassy carbon electrode as a control.  
Cyclic voltammetry of this control sample in PBS (not shown) exhibited the broad redox 
peaks attributed to the carboxylic acids groups of the functionalised MWNTs. 
 
These oxidation and reduction peaks of the MWNT-COOH groups were also observed in 
the MWNT Cov-HRP sample. In addition, an evident stable redox couple (Figure 6, 
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anodic peak A (+0.16 V) and cathodic peak A’ (+0.09 V)) was observed which may be 
attributed to the iron centre of the HRP enzyme. To verify this, a further control sample, 
constructed in the same manner as before but also containing 10 l of a 1mg ml-1 solution 
of HRP in PBS, was examined by cyclic voltammetry. A stable redox couple was 
observed from the cyclic voltammogram of this control sample (Figure 6, anodic peak A 
(+0.17 V) and cathodic peak A’ (+0.11 V) (Figure 6a)). This confirms that the redox 
couple shown at the MWNT Cov-HRP sample was due to the HRP moiety. These results 
show that direct electrical communication was achieved between the highly conductive 
CNTs and peroxidase enzymes covalently bioconjugated to their sidewalls and ends. 
 
Cyclic voltammetry of SWNTs covalently functionalised with anti-mouse IgG labelled 
with HRP, carried out in phosphate buffered saline, show an oxidation peak (A) at 0.13 V 
and a corresponding reduction peak (A’) at 0.08 V vs. Ag/AgCl, which have again been 
ascribed to the Fe (II)/Fe (III) couple of the HRP enzyme (Figure 7). This redox couple is 
not observed from the SWNT NC-HRP sample, confirming the TEM, UV-visible-NIR 
and Raman spectroscopy results, that the non-covalent immobilisation protocol was less 
successful.  
 
The cyclic voltammetric responses of CNTs functionalised with the HRP-labelled 
antibody in phosphate buffered saline (pH=7.4) to the addition of 37.5 mol dm-3 H2O2 
are shown in Figure 6b and Figure 7b. Upon addition of H2O2, the current increased 
sharply by 289 A (at 0.39 V vs. Ag/AgCl) and 114 A (at 0.49 V vs. Ag/AgCl) for the 
covalently modified SWNT and MWNT samples, respectively. The response obtained 
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confirms the electrochemical activity of HRP which was immobilised on the secondary 
antibody. In comparison, the current responses to H2O2 obtained from non-covalently 
modified SWNT and MWNT samples, under identical conditions were 17 A (Figure 7b) 
and 60 A (Figure 6b), respectively. These results demonstrate the feasibility of 
designing immunosensors for proteins by covalently binding antibodies to an 
oligosaccharide used to disperse SWNTs, resulting in a 17-fold improvement in 
sensitivity compared to non-covalently modified CNT samples. 
 
4. Conclusion 
Single wall and multi-walled carbon nanotubes were functionalised with horse radish 
peroxidase and quantum dot-labelled antibodies by two approaches, covalent and non-
covalent functionalisation. These samples were characterised using a variety of 
techniques including colorimetric enzyme and fluorescence assays, UV-visible-NIR and 
Raman spectroscopy, transmission electron microscopy and cyclic voltammetry. The 
results suggest that the covalent modification approach was successful, whereas the non-
covalent modification approach resulted in no electrochemically detectable labelled 
antibodies on the CNTs. Immobilisation was achieved without denaturing antibodies, as 
is sometimes the case for non-covalently immobilised enzymes. Finally, direct electrical 
communication between the CNTs and peroxidase-labelled antibodies was achieved 
indicating that CNTs are suitable nano-electrochemical transducers in immunoassays. 
Thus antibody-functionalised CNTs may have the potential to have the required 
sensitivity and desired portability for point of care devices. 
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Figure Captions: 
Figure 1: Functionalisation of CNTs with antibodies. Initially CNTs were conjugated 
with mouse antibodies (a). These were subsequently labelled with anti-mouse antibodies 
labelled with either HRP (b) or streptavidin-labelled quantum dots (QDOTs) (c). 
 
Figure 2: Tetramethylbenzidine (TMB) colorimetric enzyme assay results for CNTs 
functionalised with anti-mouse IgG labelled with HRP (intensity readings taken at an 
absorbance wavelength of 450 nm). Standard deviations are shown as error bars (n=3) 
which may be masked by bars. 
 
Figure 3: Fluorescence emission spectrum of SWNT Cov-QDOT and the SWNT control, 
at an excitation wavelength of 450 nm. Inset: Fluorometric assay results for CNTs 
functionalised with anti-mouse IgG labelled with biotin and streptavidin QDOTs 
(Fluorescence readings taken at an excitation wavelength of 450 nm and an emission 
wavelength of 605 nm). Standard deviations are shown as error bars (n=3) which may be 
masked by bars. 
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Figure 4: UV-visible-near infra red spectra for SWNTs functionalised with anti-mouse 
IgG labelled with HRP and QDOT. Spectra have been offset for clarity. 
 
Figure 5: Transmission electron micrographs of antibody functionalised multi-walled 
carbon nanotube samples, either covalently ((a left) MWNT Cov-HRP and (b left) 
MWNT Cov-QDOT) or non-covalently ((a right) MWNT NC-HRP and (b right) MWNT 
NC-QDOT). 
 
Figure 6: MWNT cyclic voltammetry in (a) phosphate buffered saline (PBS) as 
electrolyte and (b) PBS with 0.0375 M H2O2 at 100 mV s-1 scan rate. Left hand scale in 
(a) applies to MWNT Cov-HRP and MWNT NC-HRP and right hand scale applies to 
MWNT HRP control. 
 
Figure 7: SWNT cyclic voltammetry in (a) phosphate buffered saline (PBS) as 
electrolyte and (b) PBS with 0.0375 M H2O2 at 100 mV s-1 scan rate. 
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Figure 1: Functionalisation of CNTs with antibodies. Initially CNTs were conjugated 
with mouse antibodies (a). These were subsequently labelled with anti-mouse antibodies 
labelled with either HRP (b) or streptavidin-labelled quantum dots (QDOTs) (c). 
 
 20
 0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
SWNT-HA Cov SWNT-HA NC MWNT-COOH Cov MWNT-COOH NC
A
bs
or
ba
nc
e 
/ m
g 
C
N
T 
(a
.u
.)
 
Figure 2: Tetramethylbenzidine (TMB) colorimetric enzyme assay results for CNTs 
functionalised with anti-mouse IgG labelled with HRP (intensity readings taken at an 
absorbance wavelength of 450nm). Standard deviations are shown as error bars (n=3) 
which may be masked by bars. 
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Figure 3: Fluorescence emission spectrum of SWNT Cov-QDOT and the SWNT control, 
at an excitation wavelength of 450nm. Inset: Fluorometric assay results for CNTs 
functionalised with anti-mouse IgG labelled with biotin and streptavidin QDOTs 
(Fluorescence readings taken at an excitation wavelength of 450nm and an emission 
wavelength of 605nm). Standard deviations are shown as error bars (n=3) which may be 
masked by bars. 
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Figure 4: UV-visible-near infra red spectra for SWNTs functionalised with anti-mouse 
IgG labelled with HRP and QDOT. Spectra have been offset for clarity. 
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 (a) 
 
(b) 
Figure 5: Transmission electron micrographs of antibody functionalised multi-walled 
carbon nanotube samples, either covalently ((a left) MWNT Cov-HRP and (b left) 
MWNT Cov-QDOT) or non-covalently ((a right) MWNT NC-HRP and (b right) MWNT 
NC-QDOT). 
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(b) 
Figure 6: MWNT cyclic voltammetry in (a) phosphate buffered saline (PBS) as 
electrolyte and (b) PBS with 0.0375 M H2O2 at 100mV/s scan rate. Left hand scale in (a) 
applies to MWNT Cov-HRP and MWNT NC-HRP and right hand scale applies to 
MWNT HRP control. 
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(b) 
Figure 7: SWNT cyclic voltammetry (a) phosphate buffered saline (PBS) as electrolyte 
and (b) PBS with 0.0375 M H2O2 at 100mV/s scan rate. 
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